Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial was to evaluate the safety and efficacy of degarelix when comparing
six different doses. The patients participating in the trial were treated with degarelix
every month for a year. During the treatment the patients had to visit the clinic for
investigations. Blood samples for testosterone, dihydrotestosterone, luteinizing hormone,
follicle stimulating hormone, and Prostate Specific Antigen were taken and analysed
throughout the trial.